By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



The Hague      Netherlands
Phone: n/a Fax: n/a


Medical Device

Company News
New Data On EndoStim Therapy For The Treatment Of Gastro-Esophageal Reflux Disease (GERD) Presented At Digestive Disease Week 2016 5/31/2016 8:04:52 AM
EndoStim Names Rohan Hoare, Ph.D., As New President And CEO 5/17/2016 7:44:29 AM
EndoStim Bags $25 Million to Expand Commercialization Efforts and Conduct a Pivotal U.S. Clinical Trial 5/13/2016 6:05:56 AM
EndoStim Pulls Out of $35 Million IPO 12/10/2015 6:53:33 AM
EndoStim's Neurostimulation Therapy For Gastroesophageal Reflux Disease Approved In Brazil 12/2/2015 6:29:02 AM
EndoStim Receives CE Mark For Full Body MRI Use With EndoStim II LES Stimulation System 10/20/2015 10:03:25 AM
EndoStim's Neurostimulation Therapy For GERD Receives Permanent Reimbursement Coverage In Germany 10/13/2015 11:42:54 AM
EndoStim Release: International Multicenter Trial Results Of Endostim LES Stimulation Therapy Confirm Safety And Efficacy In Patients With GERD 7/17/2015 9:59:58 AM
EndoStim Launches Second Generation Neurostimulation Device For GERD 5/18/2015 8:13:07 AM
Excellent Three Year Results Of EndoStim Therapy For Severe Reflux Disease Presented At The SAGES Annual Meeting In Nashville. 5/5/2015 10:05:22 AM